Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
2(66.7%)
Phase 4
1(33.3%)
3Total
Phase 3(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04021498Phase 3Terminated

Simvastatin in the Prevention of Recurrent Pancreatitis

Role: lead

NCT05781243Phase 4Completed

Normal Saline Versus Lactated Ringer's Solution for Acute Pancreatitis Resuscitation

Role: lead

NCT04381169Phase 3Terminated

Aggressive Versus Non-aggressive Goal-directed Fluid Resuscitation in Acute Pancreatitis

Role: lead

NCT03650062Completed

Patient-reported Outcome Scale in Acute Pancreatitis

Role: lead

All 4 trials loaded